Yonseisarangmoa women disease hospital
Yonseisarangmoa women disease hospital
Republic of Korea, Seoul
Hong Jung Lee
27 years of experience
Clinic is certified :
Why choose the Republic of Korea for genetic test for aneuploidy up to 8 embryos?
Access advanced Genetic test for aneuploidy up to 8 embryos solutions in trusted clinics .
| Republic of Korea | Turkey | Austria | |
| Genetic test for aneuploidy up to 8 embryos | - | from $4,000 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Genetic test for aneuploidy up to 8 embryos upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Genetic test for aneuploidy up to 8 embryos and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Genetic test for aneuploidy up to 8 embryos journey.
Day 1
Day 2
Day 3 - Day 5
Day 6
Day 7 - Day 9
Day 10
Please note, this is a generalized timeline and individual experiences may vary based on each person"s unique medical history and health status.
Director of Yonsei Sarangmoa Women’s Hospital, Dr. Lee is an adjunct professor at Yonsei University and Korea University School of Medicine.
Adjunct Professor at Yonsei University and Co-Director of Yonsei Sarangmoa Women's Hospital – specializes in women's health with a focus on genetic testing.
Specializes in genetic testing for embryo aneuploidy at Yonseisarangmoa Women's Disease Hospital.
Adjunct professor at Inje University Paik Hospital – Dr. An Jea Hyeong brings academic rigor to clinical practice.
Seoul is a global hub for embryo genetic testing, with major institutions like Yonsei University Severance Hospital, Samsung Medical Center, and specialized clinics such as Maria Fertility Hospital and CHA Fertility Center offering advanced Preimplantation Genetic Testing (PGT-A) for aneuploidy using Next-Generation Sequencing (NGS) technology.
Bookimed Expert Insight: While university hospitals offer prestige, specialized centers like Yonseisarangmoa Women’s Hospital serve over 4,500 patients annually and often provide more personalized international service. These specialized clinics frequently feature surgeons with dual academic appointments at major universities, ensuring high-level expertise without the long wait times typical of large public institutions.
Patient Consensus: Patients often recommend Maria Fertility Hospital for its efficient 10–14 day turnaround on results for 8-embryo batches. Many suggest coordinating with international departments early to manage the 10–20 million KRW budget effectively during peak seasons.
South Korea restricts embryo testing under the Bioethics and Biosafety Act, permitting genetic screening only for 237 specific hereditary diseases. Legal mandates strictly prohibit sex selection and wellness trait testing. Patients must provide written informed consent at registered medical institutions for any authorized genetic procedures.
Bookimed Expert Insight: Clinics in Seoul, such as Yonseisarangmoa Women Disease Hospital, must strictly follow the 8-embryo limit. Ministry fines for exceeding this cap are severe. Expert surgeons like Dr. Hong Jung Lee maintain high standards by focusing on medical necessity. This ensures full compliance with the 2021 Bioethics Act amendments.
Patient Consensus: Patients report that the 8-embryo limit is a hard cap with no loopholes. Most recommend freezing extra embryos untested or seeking treatment in other countries for elective screening.
Genetic testing for aneuploidy (PGT-A) is primarily recommended for women aged 35 and older to reduce miscarriage risks. It is also essential for patients with recurrent pregnancy loss, multiple failed IVF transfers, or severe male factor infertility to detect chromosomal imbalances before implantation.
Bookimed Expert Insight: While some clinics suggest universal testing, specialized centers like Yonseisarangmoa Women Disease Hospital in Seoul focus on high-risk cases. Data shows that testing batches of up to 8 embryos is most cost-effective for patients with low egg yields. This targeted approach prevents unnecessary transfers of non-viable embryos without over-testing younger patients with high AMH levels.
Patient Consensus: Many patients emphasize that while testing is often recommended for older women, it provides critical peace of mind by identifying issues not visible during standard embryo grading. They suggest verifying your specific medical necessity to ensure you are not paying for unnecessary procedures.